Skip to content

Clinical study of lacrimal duct CT contrast combined with lacrimal endoscopy for the precise treatment of lacrimal obstructive diseases

Clinical study of lacrimal duct CT contrast combined with lacrimal endoscopy for the precise treatment of lacrimal obstructive diseases

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400083742
Enrollment
Unknown
Registered
2024-04-30
Start date
2024-05-01
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lacrimal obstructive diseases

Interventions

Experiencment group:CT imaging of lacrimal passage combined with endoscopic treatment of lacrimal passage
Control group:CT imaging of lacrimal passage combined with exploratory catheter placement of lacrimal passage

Sponsors

Tongji Hospital of Tongji University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Age 40-80 years old, male or female; (2) Patients with symptoms and (or) signs of lacrimal passage obstruction, namely lacrimal discharge, conjunctival sac secretions, unilateral or bilateral lacrimal passage irrigation obstruction; (3) Patients who still have symptoms and signs of lacrimal passage obstruction or lacrimal passage irrigation obstruction after only one lacrimal passage probing in our hospital or other hospitals. (4) no serious mental or systemic illness;

Exclusion criteria

Exclusion criteria: (1) The lacrimal passage flushes with viscous or purulent secretions; (2) Patients with nasal trauma or surgical history, preoperative CT lacrimal duct angiography indicating osseous obstruction of nasolacrimal duct, preoperative nasal endoscopy indicating lower nasal duct disease; (3) Special cases such as tear point atresia; (4) Patients with serious or unstable heart, liver, kidney, lung, endocrine (including thyroid insufficiency), blood, mental and neurological disorders, as well as diabetic patients; (5) Pregnant or lactating women;

Design outcomes

Primary

MeasureTime frame
Patency of lacrimal passage irrigation;

Secondary

MeasureTime frame
Patency of lacrimal passage irrigation;Munk scores;

Countries

China

Contacts

Public ContactZhangjuan

Tongji Hospital of Tongji University

juanzhang0812@163.com+86 158 8049 9969

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026